Posts Tagged ‘international’

The Scale of Africa’s Biosafety Double-Standard

This is a guest post from the BiotechBlog Intern,  Fintan Burke. Fintan is a student at the School of Biotechnology at Dublin City University. Do you have a response to Fintan’s post? Respond in the comments section below. As trade featuring Living Modified Organisms (LMOs) began to grow to an international scale during the late […]

Moving a foreign biotechnology company to the United States is easy as stealing in church

“What is the biggest challenge in moving a foreign biotechnology company to the United States?” I asked this question at the Delaware-New Jersey-Pennsylvania annual biotechnology conference and received a surprising response. The consensus was neatly stated by one of the panelists: “Moving to the US is like stealing in church.” For all the problems one […]

Pharmaceutical globalization: Where are drugs invented?

I’m back from the Filling the Pipeline conference in Boston, where I presented a talk on pharmaceutical globalization. Maintaining control of pharmaceutical drug innovation is key for national security, public health, and economic development. We know that much of late-stage development has gone overseas, but the question remains: Where are drugs invented? Using the DrugPatentWatch […]

Third Annual Scientific American Worldview: Measuring Global Biotechnology

The third issue of Scientic American’s Worldview is now available at In this latest issue I continue my comparative assessment of the biotechnology innovation environment in different countries. I also include additional highlights: Which country is home to the most drug inventors? Which country has the greatest biotechnology patenting intensity? Which country has the […]

Going Global: Partnering and Investing in International Life Sciences

I will be presenting in an upcoming webinar: Going Global Partnering and Investing in International Life Sciences   Today, successful life sciences companies are feverishly evaluating international partnerships in search of places that are rapidly expanding. Some make the costly mistake of only using market size as the deciding factor, which is often misleading. Success […]

Using patent information to track globalization

I will be giving a talk on “Using patent information to track globalization” at the ACS conference in Anaheim next week. The talk is part of the ACS Division of Chemistry and Law session on What Can Patent Information Do For Scientists, and is based on analysis of data from DrugPatentWatch. I look forward to […]

Building an R&D cluster in Okinawa

The public portion of the International Symposium Development of an R&D Cluster in Okinawa has been posted. The symposium brought experts from around the world, with a particular emphasis on regions such as San Diego, Singapore, and Israel. Complete coverage, including video links in English and Japanese are on the Okinawa Institute for Science and […]

Globalization in the pharmaceutical industry: Where are drugs invented?

I’ve just had a paper published in Nature Reviews Drug Discovery, using data from DrugPatentWatch to profile the locations of drug invention for the past decade. The location of drug development is important for two reasons. Firstly, it is important to track the global spread of innovation. Much late stage drug development (e.g. clinical trials) and […]